We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aurobindo Pharma has initiated voluntary recall of 22 batches of drug substance Irbesartan, used in treatment of hypertension from the US market due to the presence of an impurity, which is believed to cause cancer, the US Food and Drug Administration has